Afya (AFYA) Stock Price, News & Analysis

Company Overview

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

Key Stats

• Today's Range: $13.56 to $13.85
• 50-Day Range: $13.68 to $18.87
• 52-Week Range: $13.47 to $19.90
• Volume: 133,427 shs
• Average Volume: 109,105 shs
• Market Capitalization: $1.28 billion
• P/E Ratio: 10.36
• Dividend Yield: 1.68%
• Price Target: $17.40
• Consensus Rating: Reduce

Afya Stock Analysis - MarketRank™

Afya scored higher than 92% of companies evaluated by MarketBeat, and ranked 33rd out of 284 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.8 / 5
• Analyst Rating: Reduce

Consensus Rating

Afya has received a consensus rating of Reduce. The company's average rating score is 1.60, and is based on no buy ratings, 3 hold ratings, and 2 sell ratings.

Amount of Analyst Coverage

Afya has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 4.4 / 5
• Proj. Earnings Growth: 25.66%

Earnings Growth

Earnings for Afya are expected to grow by 25.66% in the coming year, from $1.52 to $1.91 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Afya is 10.36, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.09.

Price to Earnings Ratio vs. Sector

The P/E ratio of Afya is 10.36, which means that it is trading at a less expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 18.91.

Price to Earnings Growth Ratio

Afya has a PEG Ratio of 0.48. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Afya has a P/B Ratio of 1.60. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.72% of the float of Afya has been sold short.

Short Interest Ratio / Days to Cover

Afya has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Afya has recently decreased by 8.66%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Afya pays a meaningful dividend of 1.69%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Afya does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Afya is 17.42%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Afya will have a dividend payout ratio of 12.04% next year. This indicates that Afya will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.72% of the float of Afya has been sold short.

Short Interest Ratio / Days to Cover

Afya has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Afya has recently decreased by 8.66%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.69

News Sentiment

Afya has a news sentiment score of 0.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Discretionary companies.

News Coverage This Week

MarketBeat has tracked 9 news articles for Afya this week, compared to 3 articles on an average week.

Search Interest

3 people have searched for AFYA on MarketBeat in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Afya insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.80% of the stock of Afya is held by insiders.

Percentage Held by Institutions

88.02% of the stock of Afya is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

AFYA Stock Analysis - Frequently Asked Questions

How have AFYA shares performed this year?

Afya's stock was trading at $15.88 at the beginning of 2025. Since then, AFYA stock has decreased by 13.9% and is now trading at $13.68.

How were Afya's earnings last quarter?

Afya Limited (NASDAQ:AFYA) posted its quarterly earnings results on Wednesday, May, 26th. The company reported $1.16 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.56 by $0.40. The firm had revenue of $72.15 million for the quarter, compared to the consensus estimate of $72.96 million. Afya had a trailing twelve-month return on equity of 19.13% and a net margin of 19.83%.

When did Afya IPO?

Afya (AFYA) raised $233 million in an initial public offering on Friday, July 19th 2019. The company issued 13,700,000 shares at a price of $16.00-$18.00 per share. BofA Merrill Lynch, Goldman Sachs, UBS Investment Bank, Itaú BBA, Morgan Stanley, BTG and Pactual XP Investments acted as the underwriters for the IPO.

Who are Afya's major shareholders?

Afya's top institutional investors include Perpetual Ltd (0.16%), Carrera Capital Advisors (0.10%) and R Squared Ltd (0.02%).

How do I buy shares of Afya?

Shares of AFYA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Afya own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Afya investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), ServiceNow (NOW), Arista Networks (ANET), Adobe (ADBE) and CrowdStrike (CRWD).

Company Calendar

• Last Earnings: 5/26/2021
• Today: 8/02/2025
• Next Earnings (Estimated): 8/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Discretionary
• Industry: SCHOOLS
• Sub-Industry: Personal Services
• Current Symbol: NASDAQ:AFYA
• CIK: 1771007
• Web: www.afya.com.br
• Phone: 553135157550
• Fax: N/A
• Employees: 9,717
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Afya: $17.40
• High Price Target: $20.50
• Low Price Target: $14.00
• Potential Upside/Downside: +27.2%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.60
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.32
• Trailing P/E Ratio: 10.36
• Forward P/E Ratio: 9.00
• P/E Growth: 0.48
• Net Income: $117.08 million
• Net Margins: 19.83%
• Pretax Margin: 21.12%
• Return on Equity: 19.13%
• Return on Assets: 9.39%

Debt

• Debt-to-Equity Ratio: 0.41
• Current Ratio: 1.42
• Quick Ratio: 1.42

Sales & Book Value

• Annual Sales: $612.78 million
• Price / Sales: 2.09
• Cash Flow: $2.18 per share
• Price / Cash Flow: 6.27
• Book Value: $8.53 per share
• Price / Book: 1.60

Miscellaneous

• Outstanding Shares: 93,720,000
• Free Float: 92,973,000
• Market Cap: $1.28 billion
• Optionable: Optionable
• Beta: 0.53